Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPRT1 | P00492 | 4/20 | 0.58 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.50 |
| ▸ | TSHR | P16473 | 2/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.50 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.48 |
| ▸ | HPGD | P15428 | 3/20 | 0.48 |
| ▸ | THRB | P10828 | 1/20 | 0.48 |
| ▸ | POLB | P06746 | 1/20 | 0.45 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.44 |
| ▸ | FYN | P06241 | 1/20 | 0.44 |
| ▸ | MAOA | P21397 | 1/20 | 0.44 |
| ▸ | ACHE | P22303 | 1/20 | 0.44 |
| ▸ | AHR | P35869 | 1/20 | 0.44 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.43 |
| ▸ | HIF1A | Q16665 | 3/20 | 0.43 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11197647 | 0.91 | HPRT1 (0.50) | HPRT1HSD17B10ALDH1A1TSHRTDP1 | |
| SCHEMBL1377289 | 0.83 | HPRT1 (0.50) | HPRT1HSD17B10ALDH1A1TSHRTDP1 | |
| SCHEMBL3701854 | 0.79 | HPRT1 (0.82) | HPRT1HSD17B10ALDH1A1TSHRTDP1 | |
| SCHEMBL4855632 | 0.79 | HPRT1 (0.82) | HPRT1HSD17B10ALDH1A1TSHRTDP1 | |
| SCHEMBL69097 | 0.79 | HPRT1 (0.82) | HPRT1HSD17B10ALDH1A1TSHRTDP1 | |
| SCHEMBL2848750 | 0.78 | HPRT1 (0.50) | HPRT1HSD17B10ALDH1A1TSHRTDP1 | |
| SCHEMBL2679230 | 0.78 | HPRT1 (0.56) | HPRT1HSD17B10ALDH1A1TSHRTDP1 | |
| SCHEMBL4851786 | 0.77 | HPRT1 (0.78) | HPRT1HSD17B10ALDH1A1TSHRTDP1 | |
| SCHEMBL4846677 | 0.77 | HPRT1 (0.78) | HPRT1HSD17B10ALDH1A1TSHRTDP1 | |
| SCHEMBL4853390 | 0.77 | HPRT1 (0.78) | HPRT1HSD17B10ALDH1A1TSHRTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260042726-A1 | ENCODED DESIGN INTEGRATED SYNTHESIS OF NUCLEIC ACIDS, AND PHOSPHOLIPIDS, AND RELATED PHARMACEUTICAL PRODUCTS | SCHAPER CHARLES (US) | 2026-02-12 | — | — | US | disclosed |
| US-12473247-B2 | Encoded design integrated synthesis of nucleic acids, and phospholipids, and related pharmaceutical products | Schaper, Charles (US) | 2025-11-18 | — | — | US | disclosed |
| US-20250074853-A1 | ENCODED DESIGN INTEGRATED SYNTHESIS OF NUCLEIC ACIDS, AND PHOSPHOLIPIDS, AND RELATED PHARMACEUTICAL PRODUCTS | SCHAPER CHARLES (US) | 2025-03-06 | — | — | US | disclosed |
| US-12195423-B1 | Encoded design integrated synthesis of nucleic acids, and phospholipids, and related pharmaceutical products | SCHAPER CHARLES (US) | 2025-01-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12195423-B1 | Encoded design integrated synthesis of nucleic acids, and phospholipids, and related pharmaceutical products | POLRMT, TARBP1, PHOSPHO1 | HPRT1 478/4885HSD17B10 1926/4885ALDH1A1 4705/4885 |
| US-20250074853-A1 | ENCODED DESIGN INTEGRATED SYNTHESIS OF NUCLEIC ACIDS, AND PHOSPHOLIPIDS, AND RELATED PHARMACEUTICAL PRODUCTS | POLRMT, TARBP1, PHOSPHO1 | HPRT1 478/4885HSD17B10 1926/4885ALDH1A1 4705/4885 |
| US-12473247-B2 | Encoded design integrated synthesis of nucleic acids, and phospholipids, and related pharmaceutical products | POLRMT, TARBP1, PHOSPHO1 | HPRT1 478/4885HSD17B10 1926/4885ALDH1A1 4705/4885 |
| US-20260042726-A1 | ENCODED DESIGN INTEGRATED SYNTHESIS OF NUCLEIC ACIDS, AND PHOSPHOLIPIDS, AND RELATED PHARMACEUTICAL PRODUCTS | POLRMT, POLM, PHOSPHO1 | HPRT1 1907/4885HSD17B10 2189/4885ALDH1A1 3743/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.